Italia markets open in 1 hour 49 minutes

STERIS plc (STE)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
232,77-0,14 (-0,06%)
Alla chiusura: 04:00PM EST
232,77 +0,01 (+0,00%)
Dopo ore: 04:03PM EST
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente232,91
Aperto233,44
Denaro0,00 x 800
Lettera0,00 x 900
Min-Max giorno232,01 - 234,88
Intervallo di 52 settimane173,21 - 254,00
Volume357.989
Media Volume447.895
Capitalizzazione23,001B
Beta (5 anni mensile)0,80
Rapporto PE (ttm)40,98
EPS (ttm)5,68
Prossima data utili08 mag 2024 - 13 mag 2024
Rendimento e dividendo (futuro)2,08 (0,89%)
Data ex dividendo22 feb 2024
Stima target 1A240,43
  • GlobeNewswire

    STERIS to Present at the Morgan Stanley Healthcare Conference

    DUBLIN, IRELAND , Aug. 30, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Morgan Stanley Healthcare Conference in New York City on Wednesday, September 13, 2023. Dan Carestio, President and CEO of STERIS will present at 8:10 a.m. Eastern Time. A simultaneous webcast and replay of the Company’s presentation will be available on STERIS’s investor relations website at www.steris-ir.com. About STERIS STERIS is a leading global pr

  • GlobeNewswire

    STERIS Completes the Acquisition of Surgical Instrumentation Assets from BD

    DUBLIN, IRELAND, Aug. 02, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that it has completed the previously announced acquisition of the surgical instrumentation, laparoscopic instrumentation and sterilization container assets from BD (Becton, Dickinson and Company) (NYSE:BDX). “We are pleased to announce the closing of this acquisition, as the brands we are adding will strengthen, complement and expand STERIS’s product offerings within our Healthca

  • GlobeNewswire

    STERIS Announces Financial Results for Fiscal 2024 First Quarter

    First quarter revenue growth of 11% as reported and constant currency organicAs reported diluted earnings per share increased to $1.25; adjusted earnings increased to $2.00Fiscal 2024 outlook updated to reflect acquisition of BD surgical instrumentation assets DUBLIN, IRELAND, Aug. 01, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 first quarter ended June 30, 2023. Revenue as reported for the quarter increased 11